Three major gene and cell therapy organizations called for a global 10-year moratorium on heritable human genome editing, warning the technology remains too risky for clinical use. The joint statement, issued by the Alliance for Regenerative Medicine (ARM), the International Society for Cell and Gene Therapy (ISCT) and the American Society for Gene and Cell … Read more
Archyde The Future of Duchenne Muscular Dystrophy Treatment: Why Combination Therapies Are Likely the Key Imagine a future where a diagnosis of Duchenne muscular dystrophy (DMD) doesn’t automatically equate to a rapidly declining quality of life. While currently a devastating genetic disorder, recent advancements, particularly with Satellos Bioscience’s SAT-3247, are hinting at a paradigm shift … Read more
In this second segment of an interview with Managed Healthcare Executive, Phil Lambert, chief scientific officer for Satellos Bioscience Inc., in Toronto, discusses how the company’s experimental Duchenne muscular dystrophy drug might be used in combination with other drugs. Satellos’ drug, named SAT-3247 for now, is a small-molecule drug designed to trigger muscle stem cells … Read more
People with celiac disease, hyperthyroidism or hypothyroidism have a three-fold increase in the risk of developing type 1 diabetes, according to a recent study published in Diabetes, Obesity and Metabolism. Researchers, led by Steve V. Edelman, M.D., an endocrinologist and professor of medicine at UC San Diego Health, wanted to investigate the link between type … Read more
Trust and communication between HIV patients and their providers are essential parts of successful treatment; however, patients sometimes feel ignored at appointments, and some are lacking important information about managing their disease, according to the first set of results from ViiV Healthcare’s Positive Perspectives 3 survey, released today. Approximately 80% of patients trust their healthcare … Read more
Scientists at the National Institutes of Health (NIH) have created a set of gene delivery systems that can reach different neural cell types in the human brain and spinal cord. The new gene delivery tools can target key brain cell types, including excitatory neurons, inhibitory interneurons, striatal and cortical subtypes, brain blood vessel cells, and … Read more
New research is shedding light on how physical abuse can impact the severity of menopause symptoms. A Turkish study published this month in Menopause has reported that 71% of postmenopausal women reported physical abuse from their partners and 62% of postmenopausal women reported verbal abuse. Additional forms of self-reported abuse and their frequency included psychological … Read more
A mobile app designed to help detect potential skin cancer has reduced hospital referrals by more than 50% in a trial at three primary care clinics in Britain’s National Health Service. The Map My Mole app, which launched in March 2024, has reviewed more than 1,500 moles and lesions, streamlining the diagnostic process for both … Read more
Empowering Recovery: how Nurse-Led Care considerably Reduces Heart Event risk After Acute Coronary Syndrome Table of Contents Empowering Recovery: how Nurse-Led Care considerably Reduces Heart Event risk After Acute Coronary Syndrome The Scope of the Challenge: ACS in the US the ALLEPRE Study: A new Perspective on Cardiac Rehabilitation A Personalized Approach: The Power of … Read more
Nurses play a critical role in reducing serious cardiovascular events after patients experience acute coronary syndrome (ACS), according to study results presented today at the American College of Cardiology Annual Scientific Session and Expo. Patients who were counseled on heart medications and lifestyle modifications by specially trained nurses were 30% less likely to experience cardiovascular … Read more